This study investigates whether oculomotor dysfunction in individuals with post-COVID-19 condition can serve as a biomarker for cognitive impairment as demonstrated in other neurological conditions.

Given the heterogeneous nature of attention-deficit/hyperactivity disorder (ADHD) and the absence of established biomarkers, accurate diagnosis and effective ...